| Market Cap | ₹828Cr | 
| ROE | 6.13% | 
| P/E Ratio(TTM) | 41.90 | 
| EPS(TTM) | 8.88 | 
| P/B Ratio | 2.81 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.63 | 
| Book Value | 132.19 | 
| Debt to Equity | 0.26 | 
| Face Value | 10 | 
| Parent Organisation | Sakar Healthcare | 
| Managing Director | Mr. Aarsh Shah | 
| NSE Symbol | SAKAR | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%)  | 86.40  | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%)  | 39.18  | ||
| Emcure Pharmaceuticals | NA (0.00%)  | 32.65  | ||
| Wockhardt | NA (0.00%)  | -450.62  |